Guièze, Romain http://orcid.org/0000-0001-7563-580X
Eikema, Diderik-Jan
Koster, Linda
Schetelig, Johannes http://orcid.org/0000-0002-2780-2981
Sengeloev, Henrik
Passweg, Jakob http://orcid.org/0000-0001-7092-3351
Finke, Jürgen http://orcid.org/0000-0002-1799-5927
Arat, Mutlu http://orcid.org/0000-0003-2039-8557
Broers, Annoek E. C.
Stölzel, Friedrich http://orcid.org/0000-0003-0653-5332
Byrne, Jenny
Castilla-Llorente, Cristina
Dreger, Peter http://orcid.org/0000-0002-7429-8570
Eder, Matthias
Gedde-Dahl, Tobias
Kröger, Nicolaus http://orcid.org/0000-0001-5103-9966
Ribera Santasusana, Josep Maria http://orcid.org/0000-0003-1042-6024
Richardson, Deborah http://orcid.org/0000-0002-8858-923X
Rambaldi, Alessandro
Yañez, Lucrecia
Van Gelder, Michel
Drozd-Sokolowska, Joanna http://orcid.org/0000-0002-4562-6264
Raj, Kavita http://orcid.org/0000-0002-8258-354X
Yakoub-Agha, Ibrahim http://orcid.org/0000-0003-4524-8782
Tournilhac, Olivier http://orcid.org/0000-0002-9438-621X
McLornan, Donal P. http://orcid.org/0000-0003-1224-091X
Article History
Received: 23 November 2023
Revised: 20 February 2024
Accepted: 22 February 2024
First Online: 19 March 2024
Competing interests
: R.G. declares conflicts of interest with Roche, Amgen, Janssen, Abbvie, BeiGene and AstraZeneca.
: This retrospective study was approved by the Chronic Malignancies Working Party (CMWP) of EBMT.